The ability to build a mimic of the interferon-interferon receptor complex allows a hunt for unique monoclonal antibodies.
UAB is testing a tablet-based decision aid in hopes of improving outcomes for minority women with lupus and kidney disease
Published in Service to Community
Back to Top